Medigen Vaccine Biologics Corporation (TPEX:6547)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
48.35
-0.95 (-1.93%)
Apr 2, 2025, 1:30 PM CST

Medigen Vaccine Biologics Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Revenue
605.64389.62365.043,28111.51
Upgrade
Revenue Growth (YoY)
55.44%6.73%-88.87%28413.03%927.41%
Upgrade
Cost of Revenue
209.22159.4577.64975.963.87
Upgrade
Gross Profit
396.42230.22-212.62,3057.64
Upgrade
Selling, General & Admin
320.58243.44183.67148.2191.96
Upgrade
Research & Development
221.511,2011,1401,193679.56
Upgrade
Operating Expenses
542.091,4441,3241,341771.52
Upgrade
Operating Income
-145.67-1,214-1,536963.73-763.88
Upgrade
Interest Expense
-18.89-37.57-26.89-6.02-16.42
Upgrade
Interest & Investment Income
46.2583.287.612.741.48
Upgrade
Currency Exchange Gain (Loss)
38.35-0.3328.867.524.15
Upgrade
Other Non Operating Income (Expenses)
-1.628.6132.25-0.070.19
Upgrade
EBT Excluding Unusual Items
-81.57-1,160-1,494967.9-774.49
Upgrade
Gain (Loss) on Sale of Investments
-----0.06
Upgrade
Gain (Loss) on Sale of Assets
0.41---19.73
Upgrade
Other Unusual Items
0.7-19.86442.3680.54
Upgrade
Pretax Income
-80.47-1,160-1,4751,410-674.28
Upgrade
Net Income
-80.47-1,160-1,4751,410-674.28
Upgrade
Net Income to Common
-80.47-1,160-1,4751,410-674.28
Upgrade
Shares Outstanding (Basic)
329328323319277
Upgrade
Shares Outstanding (Diluted)
329328323321277
Upgrade
Shares Change (YoY)
0.10%1.50%0.73%15.82%20.08%
Upgrade
EPS (Basic)
-0.24-3.53-4.564.42-2.43
Upgrade
EPS (Diluted)
-0.24-3.53-4.564.39-2.43
Upgrade
Free Cash Flow
6.46-521.25-1,353446.26-689.22
Upgrade
Free Cash Flow Per Share
0.02-1.59-4.181.39-2.49
Upgrade
Gross Margin
65.45%59.09%-58.24%70.25%66.36%
Upgrade
Operating Margin
-24.05%-311.54%-420.85%29.37%-6638.40%
Upgrade
Profit Margin
-13.29%-297.68%-403.95%42.98%-5859.74%
Upgrade
Free Cash Flow Margin
1.07%-133.78%-370.64%13.60%-5989.55%
Upgrade
EBITDA
-26.16-1,098-1,4231,072-653.8
Upgrade
EBITDA Margin
-4.32%-281.86%-32.67%-
Upgrade
D&A For EBITDA
119.5115.64112.91108.34110.08
Upgrade
EBIT
-145.67-1,214-1,536963.73-763.88
Upgrade
EBIT Margin
-24.05%--29.37%-
Upgrade
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.